CH603547A5 - - Google Patents

Info

Publication number
CH603547A5
CH603547A5 CH1173577A CH1173577A CH603547A5 CH 603547 A5 CH603547 A5 CH 603547A5 CH 1173577 A CH1173577 A CH 1173577A CH 1173577 A CH1173577 A CH 1173577A CH 603547 A5 CH603547 A5 CH 603547A5
Authority
CH
Switzerland
Application number
CH1173577A
Inventor
Goesta Lennart Florvall
Svante Bertil Ross
Sven-Ove Ogren
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7312001A external-priority patent/SE382047B/xx
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of CH603547A5 publication Critical patent/CH603547A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
CH1173577A 1973-09-04 1974-09-03 CH603547A5 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7312001A SE382047B (sv) 1973-09-04 1973-09-04 Forfarande for framstellning av 4-aminoamfetaminderivat

Publications (1)

Publication Number Publication Date
CH603547A5 true CH603547A5 (cs) 1978-08-31

Family

ID=20318423

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1195874A CH599106A5 (cs) 1973-09-04 1974-09-03
CH1173577A CH603547A5 (cs) 1973-09-04 1974-09-03

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1195874A CH599106A5 (cs) 1973-09-04 1974-09-03

Country Status (16)

Country Link
US (1) US3996381A (cs)
JP (1) JPS5835177B2 (cs)
AT (1) AT336566B (cs)
BE (1) BE819515A (cs)
CA (1) CA1051436A (cs)
CH (2) CH599106A5 (cs)
DE (1) DE2440734C2 (cs)
DK (1) DK139716B (cs)
FI (1) FI62281C (cs)
FR (1) FR2242079B1 (cs)
GB (1) GB1461667A (cs)
HK (1) HK75778A (cs)
IE (1) IE40514B1 (cs)
LU (1) LU70852A1 (cs)
NL (1) NL7411753A (cs)
NO (2) NO139408C (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
TWI291871B (en) * 2000-11-01 2008-01-01 Cognition Pharmaceuticals Llc Pharmaceutical compositions and use of amphetamine compounds for improving memory and learning

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117160A (en) * 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
US3496195A (en) * 1966-05-11 1970-02-17 Chinoin Gyogyszer Es Vegyeszet D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts

Also Published As

Publication number Publication date
DK139716B (da) 1979-04-02
HK75778A (en) 1979-01-05
AT336566B (de) 1977-05-10
DK464774A (cs) 1975-05-05
NO791507L (no) 1975-03-05
FI62281B (fi) 1982-08-31
CA1051436A (en) 1979-03-27
FI62281C (fi) 1982-12-10
CH599106A5 (cs) 1978-05-12
FR2242079B1 (cs) 1978-07-21
DE2440734C2 (de) 1985-01-24
BE819515A (fr) 1975-03-04
AU7283374A (en) 1976-03-04
US3996381A (en) 1976-12-07
LU70852A1 (cs) 1975-06-11
NO139408B (no) 1978-11-27
IE40514L (en) 1975-03-04
NO142624B (no) 1980-06-09
FI257674A7 (cs) 1975-03-05
NL7411753A (nl) 1975-03-06
NO743177L (cs) 1975-04-01
JPS5835177B2 (ja) 1983-08-01
DK139716C (cs) 1979-09-17
GB1461667A (en) 1977-01-19
JPS5050329A (cs) 1975-05-06
NO139408C (no) 1979-03-07
FR2242079A1 (cs) 1975-03-28
NO142624C (no) 1980-09-17
DE2440734A1 (de) 1975-03-13
IE40514B1 (en) 1979-06-20
ATA702574A (de) 1976-09-15

Similar Documents

Publication Publication Date Title
AR201758A1 (cs)
AU476761B2 (cs)
AU465372B2 (cs)
AR201235Q (cs)
AR201231Q (cs)
AU474593B2 (cs)
AU474511B2 (cs)
AU474838B2 (cs)
AU471343B2 (cs)
AU465453B2 (cs)
AU465434B2 (cs)
AU450229B2 (cs)
AU476714B2 (cs)
AR201229Q (cs)
JPS5050329A (cs)
AU466283B2 (cs)
AR199451A1 (cs)
AU476696B2 (cs)
AU472848B2 (cs)
AU477823B2 (cs)
AR195948A1 (cs)
AU461342B2 (cs)
AR200256A1 (cs)
AR193950A1 (cs)
AU476873B1 (cs)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased